IQ 100
featured
CNBC launches the iQ 100 Index of large-cap innovation leaders that derive substantial revenue from their valuable intellectual property. » Read More
David Martin, M∙CAM founder & chairman, talks about the criteria his company used in compiling CNBC's IQ 100 Index which measures a company's intellectual property. » Read More |
CNBC's Dominic Chu takes a look at the companies featured in the CNBC IQ 100 Index. » Read More |
CNBC's Dominic Chu breaks down the details of the new CNBC IQ 100 Index powered by M-CAM and discusses how Apple can improve its position within the index. » Read More |
More
CNBCiQ 100 chooses companies that are consistently innovative. Those who didn't make the list don't derive substantial revenue from IP.
CNBC's Dominic Chu introduces the CNBC IQ 100, an index which contains a collection of companies that derive substantial revenue from intellectual property.
CNBC's Bob Pisani describes the CNBC IQ 100 Index powered by M-CAM. The index ranks the top 100 companies who have the best patented protected technology for future success.
David Martin, M∙CAM founder & chairman, talks about the criteria his company used in compiling CNBC's IQ 100 Index which measures a company's intellectual property.
The FDA and Congress enabled Mylan to secure a monopoly on EpiPens and then jack up the prices, says this intellectual-property expert. So why can't they just end it?
David Martin, M-CAM Founder, discusses the EpiPen pricing saga and his view that the patent office gave Mylan an unjustified monopoly on the drug.
David Martin, founder of MCAM, talks about CNBC's 2016 Disruptors list.
About IQ 100
- The CNBC IQ 100 is an exclusive, data-driven index of the 100 large-cap companies best using technology to invest in and profit from new business opportunities. It is powered by M-CAM International, a global financial institution that values patents, trademarks and other intellectual property for a deep roster of government and corporate partners.
NetNet
Billable hours are the cash cow of elite legal firms. The problem: A.I. can do much of the legal work in less time.
Pill-packing robots are working behind the scenes at pharmacies as prescription volume has boomed.
The health-care industry is shifting $100B toward tech, a boon for Americans seeking new jobs or transitioning careers.
Latest Special Reports
Covering the full set of tools and strategies for long-term investors: How to take everyday market fluctuations in stride, and when to know it’s time to take action or protect against a major economic shifts.
Take an in-depth look at the world of modern medicine - examining the treatments, companies and people making a difference in the way we treat illness and injuries today, and laying the foundation for the medical treatments of tomorrow.
Stocks
New U.S. president Donald Trump may boost spending and growth, but rising interest rates will push up funding costs.
Evercore ISI says if the corporate tax rate is cut to 20 percent, it will boost financial industry earnings by 18 percent.
Brean Capital analyst Alan Gould joins the desk to talk his bullish outlook for Netflix
